SCHEMBL24348018

SCHEMBL24348018

Cc1nc(COc2ncccn2)sc1-c1nc(-c2cc(F)c(O)c(F)c2F)cs1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BPGM P07738 6/20 0.87
CYP19A1 P11511 7/20 0.36
KDM4E B2RXH2 2/20 0.32
MAPK1 P28482 2/20 0.32
ALDH1A1 P00352 1/20 0.32
RAB9A P51151 1/20 0.32
CDC7 O00311 1/20 0.32
PLK4 O00444 1/20 0.32
DYRK3 O43781 1/20 0.32
ROCK2 O75116 1/20 0.32
MAP4K4 O95819 1/20 0.32
ROS1 P08922 1/20 0.32
MAPT P10636 1/20 0.32
PRKACA P17612 1/20 0.32
RPS6KB1 P23443 1/20 0.32
MARK3 P27448 1/20 0.32
AKT1 P31749 1/20 0.32
MAPK9 P45984 1/20 0.32
CSNK1A1 P48729 1/20 0.32
CSNK1D P48730 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24347958 0.93 BPGM (1.00) BPGMCYP19A1KDM4EMAPK1ALDH1A1
SCHEMBL26704278 0.86 BPGM (0.65) BPGMCYP19A1KDM4EMAPK1RAB9A
SCHEMBL24349273 0.85 BPGM (0.75) BPGMKDM4EMAPK1RAB9ACDC7
SCHEMBL24348422 0.85 BPGM (0.72) BPGMKDM4EMAPK1CDC7PLK4
SCHEMBL24349262 0.83 BPGM (0.72) BPGM
SCHEMBL30445504 0.82 BPGM (0.80) BPGMCYP19A1KDM4EMAPK1ALDH1A1
SCHEMBL24347962 0.82 BPGM (0.80) BPGMCYP19A1KDM4EMAPK1ALDH1A1
SCHEMBL24348463 0.81 BPGM (0.77) BPGMCYP19A1KDM4EMAPK1CDC7
SCHEMBL24348022 0.81 BPGM (0.64) BPGMCYP19A1KDM4EMAPK1ALDH1A1
SCHEMBL24349257 0.80 BPGM (0.68) BPGMKDM4EMAPK1CDC7PLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022056449-A1 COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE GENZYME CORPORATION (US) 2022-03-17 WO disclosed